Add BrightSurf on Google Email

George Washington University


Medicare overpayments for graduate medical education could total $1.28 billion annually

A study published in JAMA Internal Medicine found that Medicare overpaid hospitals by an estimated $1.28 billion annually for Graduate Medical Education (GME) programs. Capping GME payment rates could free up over $1 billion, potentially addressing doctor shortages and strengthening the physician workforce in underserved areas.

SourceGeorge Washington University·JournalJAMA Internal Medicine·DateOct 7, 2019

Many parents struggle for years to adjust after learning a child's sexual orientation

A recent study published in Archives of Sexual Behavior found that many parents experience significant difficulty adjusting to their child's sexual orientation, with some struggling for years. The researchers suggest that interventions can help speed up the adjustment process and improve the relationship between parents and children.

SourceGeorge Washington University·JournalArchives of Sexual Behavior·DateJun 18, 2019

Dermcidin may play role in the pathogenesis of skin disease hidradenitis suppurativa

Researchers at the George Washington University found dermcidin, an antimicrobial peptide, is downregulated in hidradenitis suppurativa skin, suggesting its role in disease pathogenesis. The study suggests multiple biological pathways are disrupted in HS, warranting further investigation into new therapeutic options.

SourceGeorge Washington University·JournalClinical and Experimental Dermatology·DateApr 25, 2019

Simpler parts make for a more efficient system

Researchers at George Washington University found that decentralized systems perform better when individual parts are less capable, as overly smart components lead to overcorrections and mistakes. This discovery has potential applications in company structure, autonomous vehicles, AI algorithms, and even biological evolution.

SourceGeorge Washington University·JournalScience Advances·DateFeb 6, 2019

New study finds nanoparticles show promise in therapy for triple-negative breast cancer

A new study from George Washington University Cancer Center found that nanoparticle-encapsulated doxorubicin is promising in treating triple-negative breast cancer. The smallest nanoparticles with slowest release of medication showed increased cell kill in resistant cancer cells, offering potential strategies to overcome drug resistance.

SourceGeorge Washington University·JournalPrecision Nanomedicine·DateOct 1, 2018